The core competencies of Latvian Institute of Organic Synthesis (LIOS) are medicinal chemistry and innovative drug discovery with considerable expertise in molecular modelling, organic synthesis, medicinal chemistry and preclinical drug development for the treatment of cancer, cardiovascular, antibacterial diseases and CNS disorders. The quality of LIOS has resulted in the discovery of 18 original medicines since the establishment of the institute. More than 70 original preparation methods of existing active pharmaceutical ingredients have been developed to suit the needs of the pharmaceutical industry. More www.osi.lv

The University of Antwerp is a young, dynamic and forward-thinking university. It ranks 18th in the "Top 50 Under 50 2020".

Two research groups of the Centre of Excellence Infla-Med will participate in SPRINGBOARD. Infla-Med conducts fundamental and translational research to pathophysiological processes of inflammatory diseases by using a multidisciplinary approach.

The Laboratory of Medicinal Chemistry (UAMC) has the necessary expertise to run chemical optimization programs and drive projects towards the ‘quality lead’ stage. Infectious diseases are one of the main research interests of UAMC.

The Laboratory for Microbiology, Parasitology and Hygiene  - an extended panel of in vitro and in vivo laboratory models in bacteriology, mycology and parasitology allows the study of the pathogenesis of specific infectious diseases and pharmacological evaluation of antimicrobial therapies. Extensive expertise has been acquired on discriminatory in vitro biofilm models and animal models in infectious diseases.

The University of Copenhagen is the largest institution of research and education in Denmark. In the 2014 QS, World University Rankings UCPH was ranked as number 45 worldwide and 13 in Europe.

In the project, professor Björkling group, Department of Drug Design and Pharmacology will provide expertise in the field of biopharmaceuticals comprising antisense chemotherapy, drug delivery of macromolecules, biologically active peptides and peptidomimetics, nonantibiotic anti-infective therapy.

The University of Florence (UFI) is a very well established Institution, within both the national and international panorama, successfully covering important subjects such as Life Sciences, Medicines, Engineering and Technology among others.

In the project, the University of Florence provides expertise in the field of metalloenzymes with the main focus on metalloenzymes of pharmaceutical interest – such as the carbonic anhydrases. More www.unifi.it

The University of Helsinki is the largest and most versatile university in Finland. Faculty of Pharmacy carries out leading-edge pharmaceutical research, focused on developing new tools for drug discovery. The Drug Discovery unit was considered to provide "an excellent learning environment for post-doctoral fellows and postgraduate and undergraduate students" by the Academy of Finland appointed-evaluators in the research evaluation "Chemistry Research in Finland".

The Bioactivity Screening group at the Division of Pharmaceutical Biosciences performs cutting-edge research to improve the technologies used in the early phases of drug discovery and development, with special emphasis on antimicrobials, expertise in synthetic and computational medicinal chemistry, pharmaceutical biology, in vitro assay development and high-throughput screening technologies. More www.helsinki.fi